IL17A and arthritic joint disease: The effect of low-dose (0.1 ppm) Cd was tested in an inflammatory context as would be the case in inflammatory joints, by adding or not the inflammatory cytokines IL-17 and TNF-α to synoviocytes from patients with RA and OA, a less inflammatory form of arthritis.